Tetracycline

Introduction Overview

Generic Name

tetracycline

Brand Name

Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500, Achromycin V

Dosage Form

Oral capsule, Oral tablet, Oral liquid suspension

Drug Class

Tetracyclines

Pharmacokinetics

Absorption:
Tetracycline is moderately absorbed from the gastrointestinal tract, primarily in the small intestine, with absorption occurring rapidly after oral administration. Peak plasma concentrations are generally reached within 1 to 4 hours. However, bioavailability is significantly reduced by the concomitant intake of divalent and trivalent cations such as calcium, magnesium, aluminum, iron, and zinc, due to chelation that forms non-absorbable complexes. Thus, tetracycline should be taken on an empty stomach, at least one hour before or two hours after meals or antacids to optimize absorption. Additionally, dairy products inhibit absorption since they provide a source of calcium.

Distribution:
Tetracycline is widely distributed throughout body tissues and fluids, including skin, mucous membranes, and lymphatic tissue. It crosses the placenta and is excreted into breast milk, rendering both fetuses and nursing infants vulnerable to adverse effects, particularly on bone and teeth. Tetracycline exhibits moderate plasma protein binding, approximately 60-80%, and accumulates in mineralizing tissues such as bone and developing teeth, which underlies the risk of permanent tooth discoloration and inhibition of bone growth in children under 8 years old. The volume of distribution varies but generally indicates adequate tissue penetration.

Metabolism:
Unlike many drugs, tetracycline undergoes minimal hepatic metabolism. Its pharmacologically active form remains largely unchanged, enabling it to exert its antibacterial effects. The minor metabolism that does occur involves oxidative pathways, but this is not a major route of elimination. This pharmacokinetic profile is advantageous in patients with hepatic impairment, but caution is necessary in renal impairment due to decreased clearance.

Elimination:
Tetracycline is eliminated primarily via renal excretion by glomerular filtration and tubular secretion of unchanged drug. Approximately 30-60% of an administered dose is recovered unchanged in the urine. The elimination half-life generally ranges from 6 to 12 hours but can be prolonged in cases of renal insufficiency. Non-renal routes, including fecal excretion, contribute to a lesser extent. Careful dose adjustments may be necessary in patients with compromised renal function to avoid drug accumulation and toxicities such as nephrotoxicity.

Dosage Forms

Available Dosage Forms:
Tetracycline is available in multiple oral formulations including:
- Capsules and Tablets: 250 mg, 500 mg strengths.
- Oral liquid suspension: Typically 125 mg per 5 mL and 250 mg per 5 mL concentrations.

Dosages for Adults and Adolescents:
The usual adult dosage ranges from 250 mg to 500 mg every 6 hours (4 times daily), depending on the severity and type of infection. For certain infections, initial higher dosing may be used followed by maintenance doses. It is imperative that tetracycline be taken on an empty stomach to maximize absorption. The duration typically ranges from 7 to 14 days but may be extended based on clinical response.

Specific Patient Populations:
- Pediatric Patients: Generally contraindicated in children under 8 years due to risk of permanent tooth discoloration and inhibition of bone growth.
- Pregnant and Lactating Women: Use is contraindicated during pregnancy and breastfeeding due to potential fetal and infant risks.
- Renal Impairment: Dose adjustments and careful monitoring required to prevent accumulation.
- Elderly: No specific dosage adjustment is routinely required but consider renal function.

Clinical guidelines emphasize adherence to timing and avoidance of concurrent intake with divalent/trivalent cations (e.g., antacids, dairy) to ensure efficacy.

Mechanism Of Action

Tetracycline acts primarily by inhibiting bacterial protein synthesis, thus exerting a bacteriostatic effect. Structurally, it is a broad-spectrum antibiotic belonging to the tetracycline class, sharing a four-ring naphthacene core. At the molecular level, tetracycline binds reversibly to the 30S ribosomal subunit of susceptible bacteria, particularly targeting the aminoacyl site (A site). By occupying this site, tetracycline prevents the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, effectively halting the elongation of the peptide chain during translation.

This blockade impedes bacterial protein synthesis, which is essential for growth and replication, thereby inhibiting bacterial proliferation. The selective binding affinity of tetracycline to bacterial ribosomes over mammalian ribosomes accounts for its therapeutic index. Furthermore, tetracycline penetrates bacterial cells via active transport mechanisms, which are energy-dependent, and passive diffusion, enhancing its intracellular effectiveness.

Tetracycline exhibits broad-spectrum activity against a range of Gram-positive and Gram-negative organisms, including atypical pathogens such as Chlamydia, Mycoplasma, and Rickettsia. It is also effective against certain protozoa. Clinical implications of the mechanism encompass its utility in treating diverse infections including respiratory tract infections, acne, sexually transmitted diseases, and zoonotic infections.

Comparatively, other tetracycline derivatives like doxycycline and minocycline share a similar mechanism but differ in pharmacokinetics and resistance profiles. Research has demonstrated that tetracycline resistance arises primarily through efflux pumps and ribosomal protection proteins, which reduce drug binding. Ongoing clinical studies investigate tetracycline’s role in combination therapy and its impact on microbial resistance patterns.

Pharmacological Actions

Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.
Exerts broad-spectrum bacteriostatic activity against Gram-positive and Gram-negative bacteria.
Effective against atypical bacteria such as Chlamydia, Mycoplasma, and Rickettsia.
Possesses anti-inflammatory properties beneficial in acne treatment.
Interferes with microbial replication and reduces bacterial proliferation.
Crosses cell membranes to achieve intracellular antibacterial effects.
Minimal hepatic metabolism allowing for stability of active compound.
Chelates divalent and trivalent metal ions affecting absorption.
Inhibits growth of certain protozoan parasites.
Modulates immune response through suppression of neutrophil chemotaxis in some contexts.

Therapeutic Or Clinical Uses

Treatment of severe acne vulgaris.
Management of sexually transmitted infections such as syphilis, gonorrhea, and chlamydia.
Therapy for respiratory tract infections including bronchitis and pneumonia.
Treatment of urinary tract infections.
Management of infections affecting skin, lymph nodes, and other soft tissues.
Use in zoonotic infections acquired from contact with infected animals or contaminated food (e.g., anthrax, rickettsial diseases).
Alternative treatment for infections caused by organisms resistant to penicillin.
Use in infections caused by Listeria, Clostridium, and Actinomyces species.
Treatment of certain protozoal infections.
Combination therapy in complicated bacterial infections to broaden antimicrobial spectrum.
Off-label use in periodontal disease in dentistry.
Prophylaxis in some cases of granulomatous disease and infections in immunocompromised hosts.

Side Or Adverse Effects

Nausea, vomiting, and gastrointestinal upset including diarrhea.
Photosensitivity reactions leading to increased susceptibility to sunburn.
Permanent tooth discoloration if administered to children under 8 years or during pregnancy.
Esophageal irritation or ulceration if tablets are not taken with sufficient water.
Potential development of black hairy tongue due to altered oral flora.
Allergic reactions including rash, hives, and rarely anaphylaxis.
Superinfection with resistant organisms or fungal overgrowth causing candidiasis.
Hepatotoxicity especially with high doses or intravenous administration.
Potential for nephrotoxicity, especially with outdated or expired medication.
Intracranial hypertension (benign intracranial hypertension) in rare cases.
Vaginal itching or discharge indicating possible secondary infections.
Changes in blood counts including eosinophilia occasionally reported.
Tooth enamel hypoplasia and inhibited bone growth in pediatric patients.
Rarely, hypersensitivity reactions with severe skin blistering or peeling.

Precautions

Do not administer to children under 8 years of age due to risks to bone and teeth development.
Avoid use during pregnancy and lactation owing to teratogenic and postnatal effects on infants.
Take on an empty stomach and avoid concurrent ingestion with dairy products or mineral supplements containing calcium, iron, magnesium, or aluminum.
Inform healthcare providers of pre-existing liver or kidney disease for dosage adjustments.
Use effective non-hormonal contraception as tetracycline can reduce efficacy of hormonal birth control.
Avoid prolonged sun exposure or artificial UV light sources while on therapy; use sunscreen and protective clothing.
Monitor for signs of superinfection including oral or vaginal candidiasis.
Ensure complete adherence to prescribed antibiotic course to prevent resistance development.
Discontinue therapy and seek medical attention if severe allergic reactions or skin reactions occur.
Avoid use of expired tetracycline due to risk of nephrotoxicity.
Inform dentist or surgeon prior to procedures that tetracycline therapy is ongoing.
Regular monitoring may be necessary during prolonged therapy for hepatic and renal function.
Patients should avoid antacids, laxatives, and vitamin/mineral supplements within 2 hours before or after dosing.

Warnings

Contraindicated in children younger than 8 years due to risk of permanent tooth discoloration and growth inhibition.
Use during pregnancy may harm the unborn baby and cause permanent discoloration of teeth later in life.
Expired tetracycline may cause a severe condition known as Fanconi-like syndrome leading to kidney damage.
Tetracycline can increase photosensitivity and risk of severe sunburn.
Can reduce efficacy of hormonal contraceptives leading to unintended pregnancy.
May pass into breast milk causing potential adverse effects on nursing infants; breastfeeding not recommended during treatment.
Risk of Clostridium difficile-associated diarrhea and colitis with antibiotic use.
Potential for serious hypersensitivity reactions including anaphylaxis.
Long-term use may result in superinfection with resistant bacteria or fungi.
Intracranial hypertension reported in rare cases; monitor for headache, visual changes, or papilledema.
Should be used with caution in hepatic and renal impairment due to altered pharmacokinetics.
Avoid concomitant use with drugs that reduce absorption to prevent subtherapeutic effects.

Contraindication

Hypersensitivity or allergy to tetracycline or any of the tetracycline class antibiotics including demeclocycline, doxycycline, minocycline, and tigecycline.
Children under 8 years of age due to risks of permanent tooth discoloration and bone growth inhibition.
Pregnancy due to risk of fetal harm and permanent tooth discoloration in offspring.
Severe hepatic impairment where drug metabolism and elimination may be compromised.
Patients with known history of tetracycline-associated nephrotoxicity.
Concomitant use with isotretinoin or tretinoin may exacerbate adverse effects.
Use with caution in patients with systemic lupus erythematosus due to possible exacerbation.
Known hypersensitivity to any excipients present in the formulation.

Drug Interactions

Calcium-containing products (dairy products, calcium supplements) reduce tetracycline absorption via chelation.
Magnesium, aluminum, iron, and zinc supplements or antacids interfere with gastrointestinal absorption.
Warfarin and other oral anticoagulants may have altered effects when co-administered, requiring monitoring of coagulation parameters.
Other antibiotics, particularly bactericidal agents, may have antagonistic effects when combined.
Isotretinoin and tretinoin may increase risk of intracranial hypertension when used concomitantly.
Oral contraceptives may have reduced efficacy, increasing risk of unintended pregnancy.
Potential additive hepatotoxicity when used with other hepatotoxic drugs.
Reduced efficacy if concurrently taken with laxatives affecting gastrointestinal motility.
Interactions with vitamin and mineral supplements containing iron and multivitamins.
May affect efficacy of penicillin via antagonism in some bacterial infections.
Potential interference with bactericidal antibiotics such as beta-lactams and aminoglycosides.
Possible reduction in effectiveness of antidiabetic medications.
Increased risk of photosensitivity when taken with other photosensitizing agents.
Concurrent use with methotrexate, potentially increasing toxicity.
Other prescription and over-the-counter medications, vitamins, and herbal products may interact; comprehensive medication review advised.

Preparations Of The Drug

Oral capsules and tablets available in 250 mg and 500 mg strengths for systemic antibacterial therapy.
Oral liquid suspensions, typically 125 mg/5 mL and 250 mg/5 mL, used when swallowing tablets is difficult or pediatric dosing is indicated.
Topical formulations exist but are distinct from systemic tetracycline preparations.
Special pediatric and geriatric formulations tailored for ease of dosing.
Available as generic formulations and branded products such as Sumycin, Ala-Tet, and others.
Preparation instructions emphasize storage at room temperature, protected from moisture and heat.
Formulations must be discarded after expiration due to risk of toxicity from degradation products.
Some formulations may include flavoring agents in liquid suspensions to improve palatability.
Tablet and capsule forms require administration on an empty stomach for optimal absorption.
Parenteral forms of tetracyclines exist but differ from oral tetracycline and require separate consideration.